Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at the Sarah Cannon Research Institute, posted on LinkedIn:
“Highlights for me today at Day #4 here at ASCO25?
9:45 – 11:00 am CST
Special CSS: ADCs New Targets– 3 novel targets: SEZ6, c-MET, and nectin-4
– patient perspective
– expert discussions Patricia LoRusso, DIERAS Véronique3:00 – 6:00pm CST
Oral Abstract Session, breast cancer local/adjuvant– de-escalated tx for small HER-2+
– CompassHER-2 results and HEr2DX results
– What to do with the axilla after neoadj chemo
– SOFT/ TEXT 15 year follow up – OS and tam vs. AI
– impact of ovarian suppression”
More posts featuring Erika Hamilton on OncoDaily.
Read OncoDaily’s Special Articles about ASCO 2025:
Highlights from ASCO 2025 Day 1
Highlights from ASCO 2025 Day 2
Highlights from ASCO 2025 Day 3
Highlights from ASCO 2025 Day 4
